Physician profile
Stuart M Popowitz
NPI 1750378105
$2,851.05
in general payments reported to CMS, 2019-2025
19 companies · $417 in 2025
The $417 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $404 · 2021: $472 · 2022: $425 · 2023: $292 · 2024: $393 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.64 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,217.77 | 2019-2025 | Myrbetriq, Xtandi |
| Pfizer INC. | $309.09 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $236.13 | 2023-2025 | Orgovyx, Gemtesa |
| Becton, Dickinson and Company | $216.14 | 2024-2025 | Magic3 Go Intermittent Urinary Catheter, Bard Urinary Drainage Bag |
| Terumo Medical Corporation | $142.42 | 2022 | |
| Axonics, INC. | $134.18 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.60 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $86.77 | 2019-2022 | |
| Rochester Medical Corporation | $74.17 | 2020 | |
| Janssen Biotech, INC. | $70.52 | 2019-2022 | |
| Olympus America INC. | $69.36 | 2020-2023 | Soltive |
| Neotract INC. | $53.75 | 2019 | |
| Boston Scientific Corporation | $43.44 | 2021-2022 | |
| Tolmar, INC. | $24.73 | 2025 | Eligard, Jatenzo |
| Calyxo, INC. | $20.09 | 2025 | Cvac Aspiration System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.51 | 2025 | Aptima |
| Coloplast Corp | $17.38 | 2019 | |
| Laborie Medical Technologies Corp. | $15.54 | 2022 | |
| Endo Pharmaceuticals INC. | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Popowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.